Related Experiment Videos
[Prolonged half-life of digitoxin in the elderly]
Summary
Elderly patients treated with digitoxin for heart failure experienced prolonged digitoxin half-life and intoxication, even at low doses. Reduced serum albumin may contribute to slow elimination, necessitating careful monitoring in this population.
Area of Science:
- Pharmacology
- Geriatrics
- Cardiology
Context:
- Digitoxin is a common treatment for cardiac failure in Norway.
- Digitalis glycosides can cause side effects in the elderly that mimic disease symptoms.
Purpose:
- To investigate digitoxin elimination and intoxication in elderly patients.
- To identify potential factors contributing to adverse drug reactions in this demographic.
Summary:
- Six elderly patients (77-93 years) on low-dose digitoxin (0.05 mg/day) were hospitalized for digitoxin intoxication.
- The mean digitoxin half-life was significantly prolonged (25.2 days) compared to younger patients.
- Intoxication symptoms resolved upon medication cessation; slow elimination may be linked to low serum albumin.
Impact:
- Highlights the risk of digitoxin intoxication in very elderly patients, even at low doses.
- Suggests reduced serum albumin concentration as a potential factor in delayed digitoxin elimination.
- Emphasizes the need for heightened awareness and monitoring of digitoxin therapy in geriatric cardiac patients.